Exercise Reset for Concussion in a Military Environment

NCT05498038 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2026-01-21

No results posted yet for this study

Summary

Our primary objective is to show that early, personalized aerobic exercise treatment safely improves concussion recovery, speeds RTD, and reduces persistent symptoms in CSM. Our secondary objectives include demonstrating the clinical utility of our March-in-place test and determining fundamental mechanisms for the effect of exercise rehabilitation on concussion recovery. We will conduct a prospective four-year multicenter mechanistic treatment (Phase 3) RCT in CSM of personalized sub-threshold aerobic exercise added to the PRA compared with the PRA alone. Non-concussed, age-matched SM will serve as a healthy control group (HC) for comparing CSM to normal physiology and to control for the effect of time and of aerobic exercise.

Conditions

  • Brain Concussion

Interventions

BEHAVIORAL

Aerobic Exercise

Participants are asked to complete at least 20 minutes of aerobic exercise every day, excluding clinic visits.

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED
  • Children's Hospital of Philadelphia

    collaborator OTHER
  • University of Pennsylvania

    collaborator OTHER
  • University of North Carolina, Chapel Hill

    collaborator OTHER
  • The Geneva Foundation

    collaborator OTHER
  • Center for Neuroscience and Regenerative Medicine (CNRM)

    collaborator FED
  • Axon Medical Technologies LLC

    collaborator INDUSTRY
  • State University of New York at Buffalo

    lead OTHER

Principal Investigators

  • John Leddy, MD · University at Buffalo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-07
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05498038 on ClinicalTrials.gov